retatrutide clinical trial retatrutide Availability & Timeline Retatrutide clinical trial done! Now

Injectable options GLP-1 routes may be considered after provider review

Researchers predict that US individuals born during 19651980 (Generation X) will have a higher incidence of cancer as they turn age 60 than those born during 19461964 (Baby Boomers) at the same age (41)(42)

Oral GLP-1 research: summary Oral GLP-1 pills are expanding access to weight-loss treatment

Source of funding

These claims can exaggerate the available evidence

Individual project commitments within that total include a $4.1 billion fill-finish facility at its Clayton, North Carolina campus, representing one of the largest single manufacturing investments in Novo Nordisk's history, and adding 1.4 million square feet of aseptic manufacturing and finished production space